For example, the SELECT trial clearly demonstrated that semaglutide significantly reduces the risk of major adverse cardiovascular events (MACE), leading to FDA approval for lowering the risk of cardiovascular death, myocardial infarction, or stroke in overweight or obese adults with established cardiovascular disease ( ) for reducing the risk of kidney failure and disease progression in patients with diabetes and chronic kidney disease (CKD), making it the first GLP-1 agent indicated for the treatment of CKD ( In parallel with these clinical advances, the growth of academic output has been striking
Gopukumar et al
In the first two studies, changes in redox and methylation metabolism were reported but because the studies were open-label the changes in these biomarkers were not compared to a placebo group
Some research also suggests it may affect certain parts of the brain to improve energy metabolism
Side effects of HT medications may include breast tenderness, fluid retention or bloating, headaches, breakthrough bleeding (bleeding or spotting between periods), and mood changes or irritability
Glutathione was not identified by name on the reviewed 2026 WADA list, but prohibited intravenous-infusion rules may apply depending on the volume and circumstances